404 related articles for article (PubMed ID: 28066979)
21. A quantitative model of human neurodegenerative diseases involving protein aggregation.
Kepp KP
Neurobiol Aging; 2019 Aug; 80():46-55. PubMed ID: 31102901
[TBL] [Abstract][Full Text] [Related]
22. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
Maiti P; Manna J; Veleri S; Frautschy S
Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
[TBL] [Abstract][Full Text] [Related]
23. Molecular chaperones and neuronal proteostasis.
Smith HL; Li W; Cheetham ME
Semin Cell Dev Biol; 2015 Apr; 40():142-52. PubMed ID: 25770416
[TBL] [Abstract][Full Text] [Related]
24. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
Mulligan VK; Chakrabartty A
Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
[TBL] [Abstract][Full Text] [Related]
25. Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.
Fatima MT; Islam Z; Ahmad E; Salahuddin P
Curr Protein Pept Sci; 2018; 19(9):858-875. PubMed ID: 28762306
[TBL] [Abstract][Full Text] [Related]
26. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
[TBL] [Abstract][Full Text] [Related]
27. [Neurodegenerative conformational disease and its molecular bases].
Li WW; Cai DF; Ren HM
Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic Approaches for Adapting Proteostasis in the Secretory Pathway to Ameliorate Protein Conformational Diseases.
Kelly JW
Cold Spring Harb Perspect Biol; 2020 May; 12(5):. PubMed ID: 31088828
[TBL] [Abstract][Full Text] [Related]
29. Molecular chaperone functions in protein folding and proteostasis.
Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
[TBL] [Abstract][Full Text] [Related]
30. Biological and chemical approaches to diseases of proteostasis deficiency.
Powers ET; Morimoto RI; Dillin A; Kelly JW; Balch WE
Annu Rev Biochem; 2009; 78():959-91. PubMed ID: 19298183
[TBL] [Abstract][Full Text] [Related]
31. Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases.
Pajares M; Cuadrado A; Rojo AI
Redox Biol; 2017 Apr; 11():543-553. PubMed ID: 28104575
[TBL] [Abstract][Full Text] [Related]
32. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.
Lee SJ; Lim HS; Masliah E; Lee HJ
Neurosci Res; 2011 Aug; 70(4):339-48. PubMed ID: 21624403
[TBL] [Abstract][Full Text] [Related]
33. Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.
Bose S; Cho J
Ageing Res Rev; 2017 May; 35():155-175. PubMed ID: 27702699
[TBL] [Abstract][Full Text] [Related]
34. The Nucleolus as a Proteostasis Regulator.
Amer-Sarsour F; Ashkenazi A
Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
[TBL] [Abstract][Full Text] [Related]
35. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics.
Gandhi J; Antonelli AC; Afridi A; Vatsia S; Joshi G; Romanov V; Murray IVJ; Khan SA
Rev Neurosci; 2019 May; 30(4):339-358. PubMed ID: 30742586
[TBL] [Abstract][Full Text] [Related]
36. A review on protein misfolding, aggregation and strategies to prevent related ailments.
Shamsi TN; Athar T; Parveen R; Fatima S
Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
[TBL] [Abstract][Full Text] [Related]
37. Chemical Biology Framework to Illuminate Proteostasis.
Sebastian RM; Shoulders MD
Annu Rev Biochem; 2020 Jun; 89():529-555. PubMed ID: 32097570
[TBL] [Abstract][Full Text] [Related]
38. Protein Misfolding Diseases.
Hartl FU
Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
[TBL] [Abstract][Full Text] [Related]
39. Conformational analysis of misfolded protein aggregation by FRET and live-cell imaging techniques.
Kitamura A; Nagata K; Kinjo M
Int J Mol Sci; 2015 Mar; 16(3):6076-92. PubMed ID: 25785563
[TBL] [Abstract][Full Text] [Related]
40. From Alzheimer to Huntington: why is a structural understanding so difficult?
Temussi PA; Masino L; Pastore A
EMBO J; 2003 Feb; 22(3):355-61. PubMed ID: 12554637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
